The findings suggest that individuals with certain ACE2 genotypes, particularly those with hypertension, are at a higher risk for severe COVID-19 outcomes, emphasizing the importance of understanding genetic factors in managing both cardiovascular diseases and viral infections [64]. The gene discussed is ACE2; the disease is COVID-19.